Paper33922018
A Central Role for Ischemia and OCTA Metrics to Follow DR Progression.
Cunha-Vaz J. J Clin Med, 2021. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. A Central Role for Ischemia and OCTA Metrics to Follow DR Progression. Papers, record 33922018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33922018
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 885298 | Relationship of microvascular disease in diabetes to metabolic control. | Diabetes | 1977 | https://conductscience.org/library/papers/885298 | PubMed |
| 2 | 6022598 | Studies on the effects of osmotically active substances on the circulation and structure of the retina. I. Observations in vivo. | Invest Ophthalmol | 1967 | https://conductscience.org/library/papers/6022598 | PubMed |
| 3 | 23204247 | Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy. | Diabetes Care | 2013 | https://conductscience.org/library/papers/23204247 | PubMed |
| 4 | 4138036 | Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973. | Br J Ophthalmol | 1974 | https://conductscience.org/library/papers/4138036 | PubMed |
| 5 | 32181799 | Characterization of Disease Progression in the Initial Stages of Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/32181799 | PubMed |
| 6 | 33025221 | Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression. | Acta Diabetol | 2021 | https://conductscience.org/library/papers/33025221 | PubMed |
| 7 | 30523027 | Multimodal Imaging of the Initial Stages of Diabetic Retinopathy: Different Disease Pathways in Different Patients. | Diabetes | 2019 | https://conductscience.org/library/papers/30523027 | PubMed |
| 8 | 33355147 | Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR. | Br J Ophthalmol | 2022 | https://conductscience.org/library/papers/33355147 | PubMed |
| 9 | 6360771 | Experimental galactosemia produces diabetic-like retinopathy. | Diabetes | 1984 | https://conductscience.org/library/papers/6360771 | PubMed |
| 10 | 14081839 | CAPILLARY SHUNTS IN THE PATHOGENESIS OF DIABETIC RETINOPATHY. | Diabetes | 1963 | https://conductscience.org/library/papers/14081839 | PubMed |
| 11 | 28301651 | Quantification of Retinal Microvascular Density in Optical Coherence Tomographic Angiography Images in Diabetic Retinopathy. | JAMA Ophthalmol | 2017 | https://conductscience.org/library/papers/28301651 | PubMed |
| 12 | 31382265 | Unmet Needs in Ophthalmology: A European Vision Institute-Consensus Roadmap 2019-2025. | Ophthalmic Res | 2019 | https://conductscience.org/library/papers/31382265 | PubMed |
| 13 | 34070479 | Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/34070479 | PubMed |
| 14 | 27114552 | Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27114552 | PubMed |
| 15 | 24680929 | Phenotypes and biomarkers of diabetic retinopathy. | Prog Retin Eye Res | 2014 | https://conductscience.org/library/papers/24680929 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40646245 | Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging. | Eye (Lond) | 2025 | https://conductscience.org/library/papers/40646245 | PubMed |
| 40103950 | Changes in retinal capillary density in female with type 2 diabetes and gestational diabetes-an analysis based on OCTA technology. | Int J Ophthalmol | 2025 | https://conductscience.org/library/papers/40103950 | PubMed |
| 39639890 | Progression of Capillary Hypoperfusion in Advanced Stages of Nonproliferative Diabetic Retinopathy: 6-month Analysis of RICHARD Study. | Ophthalmol Sci | 2025 | https://conductscience.org/library/papers/39639890 | PubMed |
| 34661732 | Zone-wise examination of optical coherence tomography features and their correspondence to multifocal electroretinography in eyes with nonproliferative diabetic retinopathy. | Graefes Arch Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/34661732 | PubMed |
| 34063514 | Microaneurysm Turnover in Mild Non-Proliferative Diabetic Retinopathy is Associated with Progression and Development of Vision-Threatening Complications: A 5-Year Longitudinal Study. | J Clin Med | 2021 | https://conductscience.org/library/papers/34063514 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33922018
GET https://conductscience.org/api/papers/v1/33922018/authors